EQ Long Put Strategy
EQ (Equillium, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.
EQ (Equillium, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $149.2M, a beta of 1.81 versus the broader market, a 52-week range of 0.76-3.54, average daily share volume of 706K, a public-listing history dating back to 2018, approximately 14 full-time employees. These structural characteristics shape how EQ stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.81 indicates EQ has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on EQ?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
EQ snapshot
As of August 14, 2026, spot at $2.31, ATM IV 165.00%, IV rank 31.91%, expected move 47.30%. The long put on EQ below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on EQ specifically: EQ IV at 165.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 47.30% (roughly $1.09 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EQ expiries trade a higher absolute premium for lower per-day decay. Position sizing on EQ should anchor to the underlying notional of $2.31 per share and to the trader's directional view on EQ stock.
EQ long put setup
The EQ long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EQ at $2.31 on that close, the first option leg uses a $2.31 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EQ chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EQ shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $2.31 | N/A |
EQ long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
EQ long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on EQ. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on EQ
Long puts on EQ hedge an existing long EQ stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying EQ exposure being hedged.
EQ thesis for this long put
The market-implied 1-standard-deviation range for EQ extends from approximately $1.22 on the downside to $3.40 on the upside. A EQ long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long EQ position with one put per 100 shares held. Current EQ IV rank near 31.91% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on EQ should anchor more to the directional view and the expected-move geometry. As a Healthcare name, EQ options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EQ-specific events.
EQ long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EQ positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EQ alongside the broader basket even when EQ-specific fundamentals are unchanged. Long-premium structures like a long put on EQ are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current EQ chain quotes before placing a trade.
Frequently asked questions
- What is a long put on EQ?
- A long put on EQ is the long put strategy applied to EQ (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With EQ stock at $2.31 on the most recent close, the strikes shown on this page are snapped to the nearest listed EQ chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are EQ long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the EQ long put priced from the end-of-day chain at a 30-day expiry (ATM IV 165.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a EQ long put?
- The breakeven for the EQ long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The EQ market-implied 1-standard-deviation expected move in the same options snapshot is approximately 47.30%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on EQ?
- Long puts on EQ hedge an existing long EQ stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying EQ exposure being hedged.
- How does current EQ implied volatility affect this long put?
- EQ ATM IV is at 165.00% with IV rank near 31.91%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.